BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16004705)

  • 1. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
    Stewart LB; Peters W; Robinson BL
    Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
    Miller AK; Bandyopadhyay N; Wootton DG; Duparc S; Kirby PL; Winstanley PA; Ward SA
    Eur J Clin Pharmacol; 2009 Oct; 65(10):977-87. PubMed ID: 19517101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.
    Tiono AB; Dicko A; Ndububa DA; Agbenyega T; Pitmang S; Awobusuyi J; Pamba A; Duparc S; Goh LE; Harrell E; Carter N; Ward SA; Greenwood B; Winstanley PA
    Am J Trop Med Hyg; 2009 Dec; 81(6):969-78. PubMed ID: 19996424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2003 Apr; 97(3):221-36. PubMed ID: 12803854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria.
    Wootton DG; Opara H; Biagini GA; Kanjala MK; Duparc S; Kirby PL; Woessner M; Neate C; Nyirenda M; Blencowe H; Dube-Mbeye Q; Kanyok T; Ward S; Molyneux M; Dunyo S; Winstanley PA
    PLoS One; 2008 Mar; 3(3):e1779. PubMed ID: 18320064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.
    Winstanley P
    Trop Med Int Health; 2001 Nov; 6(11):952-4. PubMed ID: 11703851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemotherapy of rodent malaria. LVIII. Drug combinations to impede the selection of drug resistance, Part. 2: The new generation--artemisinin or artesunate with long-acting blood schizontocides.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 2000 Jan; 94(1):23-35. PubMed ID: 10723521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, Part 1: Which model is appropriate?
    Peters W
    Ann Trop Med Parasitol; 1999 Sep; 93(6):569-87. PubMed ID: 10707103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy.
    Nduati EW; Kamau EM
    Acta Trop; 2006 Mar; 97(3):357-63. PubMed ID: 16457769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
    Van Malderen C; Van Geertruyden JP; Machevo S; González R; Bassat Q; Talisuna A; Yeka A; Nabasumba C; Piola P; Daniel A; Turyakira E; Forret P; Van Overmeir C; van Loen H; Robert A; D' Alessandro U
    Malar J; 2012 Jul; 11():139. PubMed ID: 22546009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorproguanil-dapsone for malaria in Africa.
    Looareesuwan S; Imwong M; Wilairatana P
    Lancet; 2004 Jun; 363(9424):1838-9. PubMed ID: 15183616
    [No Abstract]   [Full Text] [Related]  

  • 15. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
    Edstein MD; Yeo AE; Shanks GD; Rieckmann KH
    Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series.
    Fleck SL; Robinson BL; Peters W; Thévin F; Boulard Y; Glénat C; Caillard V; Landau I
    Ann Trop Med Parasitol; 1997 Jan; 91(1):25-32. PubMed ID: 9093426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 1999 Jun; 93(4):325-9. PubMed ID: 10656034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.